Opentrons

Opentrons discovered genuine demand through concrete behavioral signals from their target market. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌Lab managers and research institutions began requesting custom pipetting protocols within weeks of the founders demonstrating early prototypes at biology conferences and university labs. The team measured interest by tracking adoption rates at academic institutions—over 200 universities requested systems during their first year, with researchers actively using the open-source protocol library they'd created. Early traction manifested through repeat orders from the same institutions and unsolicited testimonials about time savings and reduced repetitive strain injuries among lab staff. The strongest validation came when researchers independently contributed their own protocols to the platform, proving they saw genuine value beyond the hardware itself. Additionally, pharmaceutical companies and diagnostic labs began integrating Opentrons systems into their workflows, demonstrating that demand extended beyond academia to commercial applications. This organic adoption pattern—where customers actively participated in building the ecosystem rather than passively consuming a product—provided evidence that the problem was real and the solution genuinely addressed a critical pain point in laboratory work.